Observational studyBreast cancer research and treatment2026
Defining prognostic subgroups and treatment outcomes in estrogen receptor low-positive de novo metastatic breast cancer.
Madelyn F Klugman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.